More on Xilinx (XLNX): FQ3 beats estimates in spite of an 8% sequential decine in sales, boosted...

|By:, SA News Editor

More on Xilinx (XLNX): FQ3 beats estimates in spite of an 8% sequential decine in sales, boosted by improved cash flows and better gross margin. The company also guides FQ4 revenue higher, now expecting to earn between $521M to $541M. Street estimates are for $511M. Shares +7.9% AH.